Replimune Group Cash from Investing (Quarterly) Trends

Replimune Group Inc (REPL)

11.16 +0.03 (+0.27%) USD | NASDAQ | Sep 27, 16:00

11.19 +0.03 (+0.27%) After-Hours: 20:00

Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2017. Upgrade now.

Date	Value
June 30, 2024	29.77M
March 31, 2024	23.20M
December 31, 2023	53.96M
September 30, 2023	12.68M
June 30, 2023	7.361M
March 31, 2023	-22.75M
December 31, 2022	-125.10M
September 30, 2022	0.036M
June 30, 2022	5.315M
March 31, 2022	-4.326M
December 31, 2021	-13.42M
September 30, 2021	-11.05M
June 30, 2021	26.99M
March 31, 2021	-126.27M
December 31, 2020	31.42M

Date	Value
September 30, 2020	-44.80M
June 30, 2020	-49.13M
March 31, 2020	7.841M
December 31, 2019	-65.21M
September 30, 2019	25.32M
June 30, 2019	26.81M
March 31, 2019	10.47M
December 31, 2018	3.801M
September 30, 2018	-85.11M
June 30, 2018	4.89M
March 31, 2018	-18.08M
December 31, 2017	-25.84M
September 30, 2017	-0.101M
June 30, 2017	-0.033M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

-126.27M

Minimum

Mar 2021

53.96M

Maximum

Dec 2023

-11.91M

Average

2.676M

Median

Cash from Investing (Quarterly) Benchmarks

Bristol-Myers Squibb Co	-1.319B
Nuvalent Inc	16.21M
NovaBay Pharmaceuticals Inc	-0.002M
Palatin Technologies Inc	0.00
iBio Inc	-0.144M

Cash from Investing (Quarterly) Related Metrics

Cash from Operations (Quarterly)	-49.17M
Cash from Financing (Quarterly)	96.64M
Free Cash Flow	-192.93M
Free Cash Flow Per Share (Quarterly)	-0.7348
Free Cash Flow Yield	-25.70%